Evaluation of potential drug interactions with sodium zirconium cyclosilicate: a single-center, open-label, one sequence crossover study in healthy adults

BACKGROUND: Sodium zirconium cyclosilicate (SZC; formerly ZS-9) is an oral potassium binder for the treatment of hyperkalemia in adults. SZC acts in the gastrointestinal tract and additionally binds hydrogen ions in acidic environments like the stomach, potentially transiently increasing gastric pH...

Descripción completa

Detalles Bibliográficos
Autores principales: Någård, Mats, Kramer, William G, Boulton, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243284/
https://www.ncbi.nlm.nih.gov/pubmed/34221388
http://dx.doi.org/10.1093/ckj/sfaa222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243284/
https://www.ncbi.nlm.nih.gov/pubmed/34221388
http://dx.doi.org/10.1093/ckj/sfaa222

Ejemplares similares